Engineers Gate Manager LP Paratek Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$4.7 - $7.24 $314,115 - $483,870
-66,833 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$6.81 - $10.93 $134,572 - $215,987
19,761 Added 41.98%
66,833 $456,000
Q1 2021

May 17, 2021
SELL
$6.14 - $8.31 $229,525 - $310,644
-37,382 Reduced 44.26%
47,072 $332,000
Q4 2020

Feb 16, 2021
BUY
$4.58 - $7.14 $386,799 - $603,001
84,454 New
84,454 $529,000

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email